Creative Medical Technology Holdings Inc (CELZ)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.01M
Last updated: Nov 17, 2026 at 11:05 AM ET
Creative Medical Technology Holdings Inc (CELZ) Earnings: Report Dates and Results
Creative Medical Technology Holdings (CELZ) is expected to report earnings on Mar 18, 2027. In the quarter ended Sep 30, 2026, Creative Medical Technology Holdings reported EPS of -$0.40, below the -$0.24 estimate. It beat the EPS estimate in 2 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
CELZ has an expected report date of Mar 18, 2027.
Earnings History
Of the 19 quarters below that had an estimate, CELZ beat 8, missed 9 and matched 2. The widest gap in the table came in the quarter ended Dec 31, 2025, when EPS landed 116.22% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.40 | -$0.24 | -$0.24 - -$0.24 | -66.67% | Miss | N/A | 1 | 0 up, 1 down | Nov 6, 2026 | N/A |
| Jun 30, 2026 | -$0.41 | -$0.39 | -$0.39 - -$0.39 | -5.13% | Miss | N/A | 1 | 0 up, 0 down | Aug 7, 2026 | N/A |
| Mar 31, 2026 | -$0.38 | -$0.39 | -$0.39 - -$0.39 | +2.56% | Beat | N/A | 1 | 0 up, 0 down | May 8, 2026 | N/A |
| Dec 31, 2025 | -$0.80 | -$0.37 | -$0.37 - -$0.37 | -116.22% | Miss | N/A | 1 | 0 up, 1 down | Mar 20, 2026 | $3000 |
| Sep 30, 2025 | -$0.48 | -$0.48 | N/A | 0.00% | In line | N/A | 1 | 0 up, 1 down | Nov 7, 2025 | N/A |
| Jun 30, 2025 | -$0.48 | -$0.63 | -$0.63 - -$0.63 | +23.81% | Beat | N/A | 1 | 0 up, 1 down | Aug 8, 2025 | N/A |
| Mar 31, 2025 | -$0.83 | -$0.52 | -$0.52 - -$0.52 | -59.62% | Miss | N/A | 1 | 1 up, 0 down | May 9, 2025 | $3000 |
| Dec 31, 2024 | -$1.12 | -$0.63 | -$0.63 - -$0.63 | -77.78% | Miss | N/A | 1 | 1 up, 0 down | Mar 14, 2025 | $3000 |
| Sep 30, 2024 | -$0.75 | -$0.85 | N/A | +11.76% | Beat | N/A | N/A | 0 up, 0 down | Nov 8, 2024 | N/A |
| Jun 30, 2024 | -$1.11 | -$0.84 | -$0.84 - -$0.84 | -32.14% | Miss | N/A | 1 | 0 up, 0 down | Aug 9, 2024 | $8000 |
| Mar 31, 2024 | -$0.73 | -$1.15 | -$1.15 - -$1.15 | +36.52% | Beat | N/A | 1 | 0 up, 0 down | May 10, 2024 | N/A |
| Dec 31, 2023 | -$1.19 | -$1.13 | -$1.13 - -$1.13 | -5.31% | Miss | N/A | 1 | 0 up, 0 down | Mar 22, 2024 | $3000 |
| Sep 30, 2023 | -$1.02 | -$0.86 | -$0.86 - -$0.86 | -18.60% | Miss | N/A | 1 | 0 up, 0 down | Nov 14, 2023 | $6000 |
| Jun 30, 2023 | -$0.78 | -$0.83 | -$0.83 - -$0.83 | +6.02% | Beat | N/A | 1 | 0 up, 0 down | Aug 11, 2023 | N/A |
| Mar 31, 2023 | -$0.70 | -$1.00 | -$1.00 - -$1.00 | +30.00% | Beat | N/A | 1 | 0 up, 0 down | May 12, 2023 | N/A |
| Dec 31, 2022 | -$0.07 | -$0.07 | N/A | 0.00% | In line | N/A | 1 | 0 up, 0 down | Mar 31, 2023 | $18600 |
| Sep 30, 2022 | -$0.70 | -$1.30 | -$1.30 - -$1.30 | +46.15% | Beat | N/A | 1 | 0 up, 0 down | Nov 10, 2022 | $55000 |
| Jun 30, 2022 | -$2.00 | -$1.50 | -$1.50 - -$1.50 | -33.33% | Miss | N/A | 1 | 0 up, 0 down | Aug 12, 2022 | N/A |
| Mar 31, 2022 | -$1.80 | -$2.30 | N/A | +21.74% | Beat | -116.1% | 1 | 0 up, 0 down | May 13, 2022 | $15000 |
| Dec 31, 2021 | -$4.16 | -$0.23 | -$0.23 - -$0.23 | N/A | N/A | N/A | 1 | 0 up, 0 down | Mar 30, 2022 | $67754 |
| Sep 30, 2021 | -$0.75 | N/A | N/A | N/A | N/A | -635.7% | N/A | N/A | Dec 6, 2021 | $10000 |
| Jun 30, 2021 | -$1.25 | N/A | N/A | N/A | N/A | -905.4% | N/A | N/A | Aug 16, 2021 | $10000 |
| Mar 31, 2021 | $11.18 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 17, 2021 | N/A |
| Dec 31, 2020 | -$31.93 | N/A | N/A | N/A | N/A | -1407.8% | N/A | N/A | Mar 17, 2021 | $17500 |
| Sep 30, 2020 | $0.14 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2020 | $77000 |
| Jun 30, 2020 | $0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2020 | $27900 |
| Mar 31, 2020 | -$5.45 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Apr 6, 2020 | $42100 |
| Dec 31, 2019 | $2.44 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2020 | N/A |
| Sep 30, 2019 | -$146.51 | N/A | N/A | N/A | N/A | -179.4% | N/A | N/A | Nov 14, 2019 | $57500 |
| Jun 30, 2019 | -$119.36 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 13, 2019 | $61600 |
| Mar 31, 2019 | -$6.22 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 20, 2019 | $50800 |
| Dec 31, 2018 | -$61.93 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2019 | $57600 |
| Sep 30, 2018 | $184.54 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2018 | $52400 |
| Jun 30, 2018 | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 2, 2018 | $4800 |
| Mar 31, 2018 | -$1.55 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2018 | $9600 |
| Dec 31, 2017 | -$6.05 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2018 | $4800 |
| Sep 30, 2017 | -$2.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 13, 2017 | N/A |
| Jun 30, 2017 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 14, 2017 | N/A |
| Mar 31, 2017 | -$1.25 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 10, 2017 | N/A |
| Dec 31, 2016 | -$0.35 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 13, 2017 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$2.59, after -$3.71 the year before. It was -$1.28 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$2.59 | N/A |
| Dec 31, 2024 | -$3.71 | N/A |
| Dec 31, 2023 | -$3.69 | N/A |
| Dec 31, 2022 | -$4.57 | -191.0% |
| Dec 31, 2021 | $5.02 | N/A |
| Dec 31, 2020 | -$37.08 | N/A |
| Dec 31, 2019 | -$269.64 | -323.3% |
| Dec 31, 2018 | $120.75 | N/A |
| Dec 31, 2017 | -$9.43 | N/A |
| Dec 31, 2016 | -$1.28 | N/A |
Frequently Asked Questions About CELZ
When is Creative Medical Technology Holdings's next earnings date?
Creative Medical Technology Holdings's next earnings report is expected for Mar 18, 2027.
Did CELZ beat earnings estimates last quarter?
No. Creative Medical Technology Holdings reported EPS of -$0.40 for the quarter ended Sep 30, 2026, below the -$0.24 estimate by 66.67%.
What EPS do analysts expect from CELZ next quarter?
The consensus EPS estimate for Creative Medical Technology Holdings for the quarter ending Dec 31, 2026 is -$0.24 from 3 analysts.
How often does CELZ beat earnings estimates?
Creative Medical Technology Holdings beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -37.38%.
CELZ pages: Overview, Earnings, Forecast, Financials, Competitors